Come up with a name for your new list and we'll add to it:
Receptor Therapeutics raised a round of funding on August 18, 2010. Investors include
MaRS Investment Accelerator Fund.
Receptor Therapeutics is a green-field start-up company seeking to in-license two or three late pre-clinical or early clinical development candidates in oncology or infectious disease. Receptor has as…